Literature DB >> 31602468

Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.

Yasuhiro Tsutani1, Atsushi Kagimoto1, Yoshinori Handa1, Takahiro Mimae1, Yoshihiro Miyata1, Morihito Okada1.   

Abstract

OBJECTIVE: The present study aimed to compare the outcomes of wedge resection and segmentectomy in patients with clinical stage I non-small-cell lung cancer (NSCLC) who were unfit for lobectomy.
METHODS: Between April 2007 and December 2015, 99 patients with stage I NSCLC who were considered unfit for lobectomy and had undergone sublobar resection were identified. Propensity scores were estimated for multivariable analyses, and surgical outcomes were compared between patients who underwent wedge resection and those who underwent segmentectomy.
RESULTS: Sixty patients underwent wedge resection and 39 underwent segmentectomy. Severe postoperative complications (>Grade IIIa) were more frequent in segmentectomy (15.4%) than in wedge resection (3.3%, P = 0.054). Propensity score-adjusted multivariable analysis revealed that operative procedure was an independent predictive factor for severe postoperative complication (segmentectomy, odds ratio = 8.18; P = 0.021). Overall survival (OS) and recurrence-free survival (RFS) were not significantly different between wedge resection (5-year OS, 61.3%, 5-year RFS, 49.4%) and segmentectomy (5-year OS, 68.2%, 5-year RFS, 56.8 %, P = 0.95, P = 0.93, respectively). Propensity score-adjusted multivariable Cox analysis revealed that operative procedure was not an independent factor for OS (segmentectomy, hazard ratio = 1.21, P = 0.62) or RFS (segmentectomy, hazard ratio = 1.07, P = 0.84).
CONCLUSION: Segmentectomy was more toxic but failed to show the superiority of survival compared with wedge resection. Wedge resection may be the optimal procedure for patients with clinical stage I NSCLC who are considered to be unfit for lobectomy.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  non–small-cell lung cancer; surgery; survival

Mesh:

Year:  2019        PMID: 31602468     DOI: 10.1093/jjco/hyz122

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  Thermal Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database.

Authors:  Chenxi Zeng; Jiawei Lu; Yitao Tian; Xiangning Fu
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244

2.  Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.

Authors:  Bo Zhang; Renwang Liu; Dian Ren; Xiongfei Li; Yanye Wang; Huandong Huo; Shuai Zhu; Jun Chen; Zuoqing Song; Song Xu
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

Review 3.  What Do We Talk About Now When We Talk About Segmentectomy for GGO?

Authors:  Hanyue Li; Chen Shen; Yang Chen; Yiyang Wang; Chenxi Zhong; Wentao Fang
Journal:  Front Surg       Date:  2022-02-15

Review 4.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  The efficacy of transbronchial indocyanine green instillation for fluorescent-guided wedge resection.

Authors:  Yasuo Sekine; Eitetsu Koh; Hidehisa Hoshino
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.